| Amgros 2027 1.1202.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Orifarm Generics A/S, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Aguettant Nordic ApS, Orifarm A/S, STADA Nordic ApS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Øresund Pharma ApS, Sun Pharmaceuticals Germany GmbH | 381.745.570 kr. | 21. oktober 2026 |
| Amgros 2027 1.701.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Macure Pharma ApS, Vantive ApS, Vantive ApS, Orifarm A/S, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Amgen Filial Af Amgen Ab Sverige, Galderma Nordic AB, Galenica AB, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Orion Pharma A/S, Teva Denmark A/S, Strides Nordic ApS, GHN Pharma Nordic AB, Macure Pharma ApS, Novartis Healthcare A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Orion Pharma A/S | 899.151.051 kr. | 15. oktober 2026 |
| Amgros 2027 1.701.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Macure Pharma ApS, Vantive ApS, Vantive ApS, Orifarm A/S, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Amgen Filial Af Amgen Ab Sverige, Galderma Nordic AB, Galenica AB, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Orion Pharma A/S, Teva Denmark A/S, Strides Nordic ApS, GHN Pharma Nordic AB, Macure Pharma ApS, Novartis Healthcare A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Orion Pharma A/S | 899.151.051 kr. | 15. oktober 2026 |
| Amgros 2027 1.701.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Macure Pharma ApS, Vantive ApS, Vantive ApS, Orifarm A/S, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Amgen Filial Af Amgen Ab Sverige, Galderma Nordic AB, Galenica AB, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Orion Pharma A/S, Teva Denmark A/S, Strides Nordic ApS, GHN Pharma Nordic AB, Macure Pharma ApS, Novartis Healthcare A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Orion Pharma A/S | 899.151.051 kr. | 15. oktober 2026 |
| Amgros 2027 1.701.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Macure Pharma ApS, Vantive ApS, Vantive ApS, Orifarm A/S, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Amgen Filial Af Amgen Ab Sverige, Galderma Nordic AB, Galenica AB, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Orion Pharma A/S, Teva Denmark A/S, Strides Nordic ApS, GHN Pharma Nordic AB, Macure Pharma ApS, Novartis Healthcare A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Orion Pharma A/S | 899.151.051 kr. | 15. oktober 2026 |
| Amgros 2027 1.701.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Macure Pharma ApS, Vantive ApS, Vantive ApS, Orifarm A/S, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Amgen Filial Af Amgen Ab Sverige, Galderma Nordic AB, Galenica AB, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Orion Pharma A/S, Teva Denmark A/S, Strides Nordic ApS, GHN Pharma Nordic AB, Macure Pharma ApS, Novartis Healthcare A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Orion Pharma A/S | 899.151.051 kr. | 15. oktober 2026 |
| Amgros 2027 1.701.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Macure Pharma ApS, Vantive ApS, Vantive ApS, Orifarm A/S, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Amgen Filial Af Amgen Ab Sverige, Galderma Nordic AB, Galenica AB, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Orion Pharma A/S, Teva Denmark A/S, Strides Nordic ApS, GHN Pharma Nordic AB, Macure Pharma ApS, Novartis Healthcare A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Orion Pharma A/S | 899.151.051 kr. | 15. oktober 2026 |
| Amgros 2027 1.701.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Macure Pharma ApS, Vantive ApS, Vantive ApS, Orifarm A/S, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Amgen Filial Af Amgen Ab Sverige, Galderma Nordic AB, Galenica AB, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Orion Pharma A/S, Teva Denmark A/S, Strides Nordic ApS, GHN Pharma Nordic AB, Macure Pharma ApS, Novartis Healthcare A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Orion Pharma A/S | 899.151.051 kr. | 15. oktober 2026 |
| Amgros 2027 1.701.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Macure Pharma ApS, Vantive ApS, Vantive ApS, Orifarm A/S, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Amgen Filial Af Amgen Ab Sverige, Galderma Nordic AB, Galenica AB, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Orion Pharma A/S, Teva Denmark A/S, Strides Nordic ApS, GHN Pharma Nordic AB, Macure Pharma ApS, Novartis Healthcare A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Orion Pharma A/S | 899.151.051 kr. | 15. oktober 2026 |
| Amgros 2027 1.701.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Macure Pharma ApS, Vantive ApS, Vantive ApS, Orifarm A/S, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Amgen Filial Af Amgen Ab Sverige, Galderma Nordic AB, Galenica AB, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Orion Pharma A/S, Teva Denmark A/S, Strides Nordic ApS, GHN Pharma Nordic AB, Macure Pharma ApS, Novartis Healthcare A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Orion Pharma A/S | 899.151.051 kr. | 15. oktober 2026 |
| Amgros 2027 2.210.a | Amgros I/S | Teva Denmark A/S, Teva Denmark A/S, Abacus Medicine A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Teva Denmark A/S, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Abacus Medicine A/S, Orifarm A/S, Orifarm A/S, Nordic Prime ApS | 51.724.677 kr. | 13. oktober 2026 |
| Amgros 2027 2.210.a | Amgros I/S | Teva Denmark A/S, Teva Denmark A/S, Abacus Medicine A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Teva Denmark A/S, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Abacus Medicine A/S, Orifarm A/S, Orifarm A/S, Nordic Prime ApS | 51.724.677 kr. | 13. oktober 2026 |
| Amgros 2027 2.703.b | Amgros I/S | Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS | 256.349.795 kr. | 13. oktober 2026 |
| Amgros 2027 2.703.b | Amgros I/S | Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS | 256.349.795 kr. | 13. oktober 2026 |
| Amgros 2027 2.703.b | Amgros I/S | Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS | 256.349.795 kr. | 13. oktober 2026 |
| Amgros 2027 2.703.b | Amgros I/S | Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS | 256.349.795 kr. | 13. oktober 2026 |
| Amgros 2027 2.703.b | Amgros I/S | Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS | 256.349.795 kr. | 13. oktober 2026 |
| Amgros 2027 2.703.b | Amgros I/S | Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS | 256.349.795 kr. | 13. oktober 2026 |
| Amgros 2027 1.1173.a | Amgros I/S | FrostPharma AB, Zentiva Denmark ApS, Sun Pharmaceuticals Germany GmbH, Devatis GmbH | 690.479.003 kr. | 10. august 2026 |